Vitamin K-Dependent Proteins as Predictors of Valvular Calcifications and Mortality in Hemodialysis Patients
Abstract
:1. Introduction
2. Materials and Methods
2.1. Patient Population
2.2. Clinical and Biochemical Evaluation
2.3. Follow-Up
2.4. Statistical Analysis
3. Results
Survival Analysis
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Cozzolino, M.; Mangano, M.; Stucchi, A. Cardiovascular disease in dialysis patients. Nephrol. Dial. Transplant. 2018, 33 (Suppl. S3), iii28–iii34. [Google Scholar] [CrossRef] [PubMed]
- Kipourou, K.; O’Driscoll, J.M.; Sharma, R. Valvular Heart Disease in Patients with Chronic Kidney Disease. Eur. Cardiol. 2022, 17, e02. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Brandenburg, V.M.; Schuh, A.; Kramann, R. Valvular Calcification in Chronic Kidney Disease. Adv. Chronic Kidney Dis. 2019, 26, 464–471. [Google Scholar] [CrossRef] [PubMed]
- Fusaro, M.; Gallieni, M.; Porta, C.; Nickolas, T.L.; Khairallah, P. Vitamin K effects in human health: New insights beyond bone and cardiovascular health. J. Nephrol. 2020, 33, 239–249. [Google Scholar] [CrossRef]
- Fusaro, M.; Tondolo, F.; Gasperoni, L. The Role of Vitamin K in CKD-MBD. Curr. Osteoporos. Rep. 2022, 20, 65–77. [Google Scholar] [CrossRef]
- Barrett, H.; O’Keeffe, M.; Kavanagh, E. Is Matrix Gla Protein Associated with Vascular Calcification? A Systematic Review. Nutrients 2018, 10, 415. [Google Scholar] [CrossRef]
- Roumeliotis, S.; Dounousi, E.; Eleftheriadis, T. Association of the Inactive Circulating Matrix Gla Protein with Vitamin K Intake, Calcification, Mortality, and Cardiovascular Disease: A Review. Int. J. Mol. Sci. 2019, 20, 628. [Google Scholar] [CrossRef]
- Cranenburg, E.C.M.; Schurgers, L.J.; Uiterwijk, H.H. Vitamin K intake and status are low in hemodialysis patients. Kidney Int. 2012, 82, 605–610. [Google Scholar] [CrossRef]
- Griffin, T.P.; Islam, M.N.; Wall, D.; Ferguson, J.; Griffin, D.G.; Griffin, M.D.; O’Shea, P.M. Plasma dephosphorylated-uncarboxylated Matrix Gla-Protein (dp-ucMGP): Reference intervals in Caucasian adults and diabetic kidney disease biomarker potential. Sci. Rep. 2019, 9, 18452. [Google Scholar] [CrossRef]
- Huish, S.; Sinha, S. New therapeutic perspectives for vascular and valvular calcifications in chronic kidney disease. Curr. Opin. Nephrol. Hypertens. 2024, 33, 391–397. [Google Scholar] [CrossRef] [PubMed]
- Thompson, S.; James, M.; Wiebe, N.; Hemmelgarn, B.; Manns, B.; Klarenbach, S.; Tonelli, M. Cause of Death in Patients with Reduced Kidney Function. J. Am. Soc. Nephrol. 2015, 26, 2504–2511. [Google Scholar] [CrossRef] [PubMed]
- Kurnatowska, I.; Grzelak, P.; Masajtis-Zagajewska, A.; Kaczmarska, M.; Stefańczyk, L.; Vermeer, C.; Maresz, K.; Nowicki, M. Plasma Desphospho-Uncarboxylated Matrix Gla Protein as a Marker of Kidney Damage and Cardiovascular Risk in Advanced Stage of Chronic Kidney Disease. Kidney Blood Press Res. 2016, 41, 231–239. [Google Scholar] [CrossRef] [PubMed]
- Wikstrøm, S.; Lentz, K.A.; Hansen, D.; Rasmussen, L.M.; Jakobsen, J.; Hansen, H.P.; Andersen, J.R. Causes of Vitamin K Deficiency in Patients on Haemodialysis. Nutrients 2020, 12, 2513. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Wei, F.-F.; Trenson, S.; Thijs, L.; Huang, Q.-F.; Zhang, Z.-Y.; Yang, W.-Y.; Moliterno, P.; Allegaert, K.; Boggia, J.; Janssens, S.; et al. Desphospho-uncarboxylated matrix Gla protein is a novel circulating biomarker predicting deterioration of renal function in the general population. Nephrol. Dial. Transplant. 2018, 33, 1122–1128. [Google Scholar] [CrossRef] [PubMed]
- Schurgers, L.J.; Barreto, D.V.; Barreto, F.C.; Liabeuf, S.; Renard, C.; Magdeleyns, E.J.; Vermeer, C.; Choukroun, G.; Massy, Z.A. The circulating inactive form of matrix gla protein is a surrogate marker for vascular calcification in chronic kidney disease: A preliminary report. Clin. J. Am. Soc. Nephrol. 2010, 5, 568–575. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Schlieper, G.; Westenfeld, R.; Krüger, T.; Cranenburg, E.C.; Magdeleyns, E.J.; Brandenburg, V.M.; Djuric, Z.; Damjanovic, T.; Ketteler, M.; Vermeer, C.; et al. Circulating nonphosphorylatedcarboxylated matrix gla protein predicts survival in ESRD. J. Am. Soc. Nephrol. 2011, 22, 387–395. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Zhang, S.; Guo, L.; Bu, C. Vitamin K status and cardiovascular events or mortality: A meta-analysis. Eur. J. Prev. Cardiol. 2019, 26, 549–553. [Google Scholar] [CrossRef] [PubMed]
- Mazur, P.; Kopytek, M.; Ząbczyk, M.; Undas, A.; Natorska, J. Towards Personalized Therapy of Aortic Stenosis. J. Pers. Med. 2021, 11, 1292. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Maher, E.R.; Young, G.; Smyth-Walsh, B.; Pugh, S.; Curtis, J.R. Aortic and mitral valve calcification in patients with end-stage renal disease. Lancet 1987, 2, 875–877. [Google Scholar] [CrossRef]
- Rossi, A.; Barbieri, A.; Benfari, G.; Gaibazzi, N.; Erlicher, A.; Mureddu, G.; Frattini, S.; Faden, G.; Manicardi, M.; Beraldi, M.; et al. Heart valve calcification and cardiac hemodynamics. Echocardiography 2021, 38, 525–530. [Google Scholar] [CrossRef] [PubMed]
- Capoulade, R.; Côté, N.; Mathieu, P.; Chan, K.L.; Clavel, M.-A.; Dumesnil, J.G.; Teo, K.K.; Tam, J.W.; Fournier, D.; Després, J.-P.; et al. Circulating levels of matrix gla protein and progression of aortic stenosis: A substudy of the Aortic Stenosis Progression Observation: Measuring effects of rosuvastatin (ASTRONOMER) trial. Can. J. Cardiol. 2014, 30, 1088–1095. [Google Scholar] [CrossRef] [PubMed]
- Ueland, T.; Gullestad, L.; Dahl, C.P.; Aukrust, P.; Aakhus, S.; Solberg, O.G.; Vermeer, C.; Schurgers, L.J. Undercarboxylated matrix Gla protein is associated with indices of heart failure and mortality in symptomatic aortic stenosis. J. Intern. Med. 2010, 268, 483–492. [Google Scholar] [CrossRef] [PubMed]
- Reda, S.; Fawzy, O.; Sayed, D.; Mohamed, G.; Khidr, E.G. Inactive Matrix Gla Protein in Relation to Renal and Cardiac Functions and Cardiac Valvular Calcification Among Type 2 Diabetes Patients. Clin. Med. Insights Endocrinol. Diabetes 2023, 16, 11795514231203862. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Palamar, M.; Grosu, I.; Schiller, A.; Petrica, L.; Bodea, M.; Sircuta, A.; Rusan, C.; Tanasescu, D.M.; Bob, F. Vitamin K Status of Patients Undergoing Hemodialysis: Insights from a Cross-Sectional Study. Appl. Sci. 2023, 13, 10938. [Google Scholar] [CrossRef]
- Mii, S.; Tanaka, K.; Matsuda, D.; Kurose, S.; Guntani, A.; Yamashita, S.; Komori, K. Peak Aortic Valve Jet Velocity is an Independent Predictor of Mortality of Dialysis Patients Undergoing Open Surgery for Chronic Limb Threatening Ischemia. Ann. Vasc. Surg. 2024, 99, 65–74. [Google Scholar] [CrossRef] [PubMed]
- Adel, H.; Fawzy, O.; Mahmoud, E.; Mohammed, N.S.; Khidr, E.G. Inactive matrix Gla protein in relation to diabetic retinopathy in type 2 diabetes. J. Diabetes Metab. Disord. 2023, 22, 603–610. [Google Scholar] [CrossRef]
- Li, C.; Li, J.; He, F.; Li, K.; Li, X.; Zhang, Y. Matrix Gla protein regulates adipogenesis and is serum marker of visceral adiposity. Adipocyte 2020, 9, 68–76. [Google Scholar] [CrossRef]
- Schweighofer, N.; Colantonio, C.; Haudum, C.W.; Hutz, B.; Kolesnik, E.; Schmidt, A.; Zirlik, A.; Pieber, T.R.; Verheyen, N.; Obermayer-Pietsch, B. Is MGP an inflammatory marker? Endocr. Abstr. 2022, 81, EP368. [Google Scholar] [CrossRef]
- Potjewijd, J.; Tobal, R.; Boomars, K.A.; van Empel, V.V.P.M.; de Vries, F.; Damoiseaux, J.G.M.C.; Schurgers, L.J.; van Paassen, P. Plasma Dephosphorylated-Uncarboxylated Matrix Gla-Protein in Systemic Sclerosis Patients: Biomarker Potential for Vascular Calcification and Inflammation. Diagnostics 2023, 13, 3526. [Google Scholar] [CrossRef]
- Donaldson, C.J.; Harrington, D.J. Therapeutic warfarin use and the extrahepatic functions of vitamin K-dependent proteins. Br. J. Biomed. Sci. 2017, 74, 163–169. [Google Scholar] [CrossRef]
- Venardos, N.; Gergen, A.K.; Jarrett, M.; Weyant, M.J.; Reece, T.B.; Meng, X.; Fullerton, D.A. Warfarin Induces Calcification of the Aortic Valve Through Extracellular Signal-regulated Kinase 1/2 and β-catenin Signaling. Ann. Thorac. Surg. 2022, 113, 824–835. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Small, A.M.; Yutzey, K.E.; Binstadt, B.A.; Key, K.V.; Bouatia-Naji, N.; Milan, D.; Aikawa, E.; Otto, C.M.; Hilaire, C.S. Unraveling the Mechanisms of Valvular Heart Disease to Identify Medical Therapy Targets: A Scientific Statement From the American Heart Association. Circulation 2024, 150, e109–e128. [Google Scholar] [CrossRef] [PubMed]
- Vahanian, A.; Beyersdorf, F.; Praz, F.; Milojevic, M.; Baldus, S.; Bauersachs, J.; Capodanno, D.; Conradi, L.; De Bonis, M.; De Paulis, R.; et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur. Heart J. 2022, 43, 561–632. [Google Scholar] [CrossRef] [PubMed]
- Kumric, M.; Borovac, J.A.; Ticinovic Kurir, T.; Martinovic, D.; Frka Separovic, I.; Baric, L.; Bozic, J. Role of Matrix Gla Protein in the Complex Network of Coronary Artery Disease: A Comprehensive Review. Life 2021, 11, 737. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
Variable | Mean Values ± Standard Deviations at Baseline | Mean Values ± Standard Deviations at Follow-Up |
---|---|---|
Serum albumin (g/dL) | 3.66 ± 0.2792 | 3.8 ± 0.4 |
Hemoglobin (g/dL) | 11.09 ± 1.183 | 10.6 ± 1.4 |
Hematocrit (%) | 33.76 ± 3.74 | 32.2 ± 4.3 |
Serum ferritin (ng/mL) | 529.4 ± 530.6 | 455.5 ± 477.4 |
Serum calcium (mg/dL) | 9.18 ± 0.82 | 9.1 ± 0.6 |
Serum phosphorus (mg/dL) | 5.63 ± 1.41 | 5.2 ± 1.4 |
iPTH (pg/mL) | 198.12 ± 130.1 | 289.6 ± 262.2 |
Bicarbonate (mEq/L) | 21.46 ± 2.578 | 21.18 ± 2.26 |
Predialysis K (mmol/L) | 5.47 ± 1 | 4.9 ± 0.8 |
CRP (mg/dL) | 14.71 ± 15.34 | 15.8 ± 38.1 |
Parameter (at Baseline) | Number of Patients (out of 45) | Percentage |
---|---|---|
Mitral stenosis | 25 | 55.55% |
Mitral insufficiency | 37 | 82.22% |
Aortic stenosis | 7 | 16% |
Aortic insufficiency | 22 | 49% |
Tricuspid stenosis | 0 | 0 |
Tricuspid insufficiency | 38 | 84.44% |
Pulmonary stenosis | 0 | 0 |
Pulmonary insufficiency | 1 | 2% |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Palamar, M.; Grosu, I.D.; Schiller, A.; Petrica, L.; Bodea, M.; Sircuta, A.; Gruescu, E.; Matei, O.D.; Tanasescu, M.D.; Golet, I.; et al. Vitamin K-Dependent Proteins as Predictors of Valvular Calcifications and Mortality in Hemodialysis Patients. Biomedicines 2025, 13, 48. https://doi.org/10.3390/biomedicines13010048
Palamar M, Grosu ID, Schiller A, Petrica L, Bodea M, Sircuta A, Gruescu E, Matei OD, Tanasescu MD, Golet I, et al. Vitamin K-Dependent Proteins as Predictors of Valvular Calcifications and Mortality in Hemodialysis Patients. Biomedicines. 2025; 13(1):48. https://doi.org/10.3390/biomedicines13010048
Chicago/Turabian StylePalamar, Marcel, Iulia Dana Grosu, Adalbert Schiller, Ligia Petrica, Madalina Bodea, Alexandru Sircuta, Elisabeta Gruescu, Oana Daniela Matei, Maria Daniela Tanasescu, Ionut Golet, and et al. 2025. "Vitamin K-Dependent Proteins as Predictors of Valvular Calcifications and Mortality in Hemodialysis Patients" Biomedicines 13, no. 1: 48. https://doi.org/10.3390/biomedicines13010048
APA StylePalamar, M., Grosu, I. D., Schiller, A., Petrica, L., Bodea, M., Sircuta, A., Gruescu, E., Matei, O. D., Tanasescu, M. D., Golet, I., & Bob, F. (2025). Vitamin K-Dependent Proteins as Predictors of Valvular Calcifications and Mortality in Hemodialysis Patients. Biomedicines, 13(1), 48. https://doi.org/10.3390/biomedicines13010048